Shire
Europe, Dublin, Ireland, Dublin'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
Description
Shire biotechnology company that focuses on serving people with rare diseases.
Investor Profile
Shire has backed more than 12 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 17% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series D rounds (top funding stages).
- Majority of deals are located in United States, Belgium, France.
- Strong thematic focus on Biotechnology, Therapeutics, Health Care.
Stage Focus
- Series B (33%)
- Series C (25%)
- Series D (17%)
- Series A (17%)
- Series Unknown (8%)
Country Focus
- United States (75%)
- Belgium (17%)
- France (8%)
Industry Focus
- Biotechnology
- Therapeutics
- Health Care
- Life Science
- Biopharma
- Pharmaceutical
- Medical
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
